New directions in testicular cancer; molecular determinants of oncogenesis and treatment success

European Journal of Cancer

Volumn 39, Issue 2, 2003, Pages 147-156

  Jones, Rob H ^a   Vasey, P A ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Apoptosis; bcl 2; Chemo sensitivity; Cyclin; p53; Retinoblastoma; Seminoma; Teratoma

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE; CYTOTOXIC AGENT; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN C KIT; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL SURVIVAL; CHEMOSENSITIVITY; DNA REPAIR; DRUG EFFICACY; GENETIC VARIABILITY; GERM CELL TUMOR; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; SPERMATOGENESIS; TESTIS CARCINOMA; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA REPAIR; GENES, BCL-2; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; MALE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-MDM2; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 0037220384     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00612-3     Document Type: Article

References (45)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
2. Looijenga L.H.J., Oosterhuis J.W. Pathogenesis of testicular germ cell tumours. Rev. Reprod. 4:1999;90-100.
3. Chaganti R.S.K., Houldsworth J. Genetics and biology of adult human male germ cell tumours. Cancer Res. 60:2000;1475-1482.
4. Diekmann K.P., Skakkebaek N.E. Carcinoma in situ of the testis, review of biological and clinical features. Int. J. Cancer. 83:1999;815-822.
5. L and sensitises human testicular germ cell tumours to chemotherapy induced apoptosis. Oncogene. 18:1999;1457-1464.
6. Korsmeyer S.J. Regulators of cell death. Trends Genet. 11:1995;101-105.
7. Chresta C.M., Masters J.R., Hickman J.A. Hypersensitivity of human testicular tumours to etoposide induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res. 56:1996;1834-1841.
8. Lane D.P. p53 and human cancers. Br. Med. Bull. 50:1994;582-599.
9. Lutzker S.G., Levine A.J. A functionally inactive p53 protein in teratocarcinoma cells is activated either by DNA damage or cellular differentiation. Nat. Med. 2:1996;804-810.
10. Dumaz N., Meek D.W. Serine 15 phosphorylation stimumlates p53 transactivation but does not directly influence interation with MDM2. EMBO J. 18:1999;7602-7607.
11. Houldsworth J., Xiao H., Murty V.V.V.S.et al. Human male germ cell tumour resistance to TP53 gene mutation. Oncogene. 16:1998;2345-2349.
12. Lutzker S.G., Mathew R., Taller D.R. A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells. Oncogene. 20:2001;2982-2986.
13. Kersemaekers A.M., Mayer F., Molier ?.et al. Role of p53 and MDM2 in treatment response of human germ cell tumours. J. Clin. Oncol. 20:2002;1551-1561.
14. Curtin J.C., Dragnev K.H., Sekula D.et al. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation fuction. Oncogene. 20:2001;2559-2569.
15. Ashcroft M., Vousden K.H. Regulation of p53 stability. Oncogene. 18:1999;7637-7643.
16. Datta M., Macri E., Signoretti S.et al. Transition from in situ to invasive testicular germ cell neoplasia is associated with loss of p21 and gain of mdm-2 expression. Mod. Pathol. 14:2001;437-442.
17. Eid H., Institoris E., Geczi G.et al. mdm-2 expression in human testicular germ-cell tumours and its clinical value. Anticancer Res. 12:1999;3485-3490.
18. Koberle B., Masters J.R.W., Hartley J.A.et al. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Current Biol. 9:1999;273-276.
19. Robertson K.A., Bullock H.A., Xu Y.et al. Altered expression of Ape 1/ref-1 in germ cell tumours and over expression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res. 61:2001;2220-2225.
20. Shaheen M.F., Robertson K., Kelley M.et al. The relationship of cytoplasmic AP endonuclease (Ape1/ref-1) expression aand chemoresistance in germ cell tumors. Proc. Am. Soc. Clin. Oncol. 21:2002;. (abstr 793).
21. Mayer F., Gillis A.J.M., Dinjens W.et al. Microsatellite instability of germ cell tumours is associated with resistance to systemic treatment. Cancer Res. 62:2002;2758-2760.
22. Mendelson J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 19:2000;6550-6565.
23. Moroni M., Veronese S., Schiavo R.et al. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumours. Clin Cancer Res. 7:2001;2770-2775.
24. Kollmannsberger C., Mayer F., Pressler H.et al. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer. Cancer. 95:2002;301-308.
25. Madani A., Kemmer K., Sweeny C.et al. Expression of Kit and epidermal growth factor receptor (EGFR) in chemotherapy refractory non-seminomatous germ cell tumors. Proc. Am. Soc. Clin. Oncol. 21:2002;. (abstr. 738).
26. Kollmannsberger C., Pressler H., Mayer F.et al. Cisplatin-refractory, HER2/neu-expressing germ-cell cancer. induction of remission by the monoclonal antibody Trastuzumab Ann Oncol. 10:1999;1393-1394.
27. Van Osterom A.T., Judson I., Verweij J.et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours. a phase 1 study Lancet. 358:2001;1421-1423.
28. Nakayama H., Nishiyama H., Higuchi T.et al. Change in cyclin D2 expression during murine testis development detected by fragmented cDNA subtraction method. Dev Growth Differ. 38:1996;141-151.
29. Sicinski P., Donaher J.L., Geng Y.et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (Lond). 384:1996;470-474.
30. Schmidt B.A., Rose A., Steinhoff C.et al. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase2/cyclin E in testicular germ cell tumours. Cancer Res. 61:2001;4214-4221.
31. Houldsworth J., Reuter V., Bosl G.J.et al. Aberrant expression of cyclin D2 is an early event in human male germ cell tumourigenesis. Cell Growth Differ. 8:1997;293-299.
32. Hall M., Peters G. Genetic alterations of cyclins, cyclin dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 68:1996;67-108.
33. Zindy F., van Deursen J., Grosveld G.et al. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20:2000;372-378.
34. Bartkova J., Thullberg M., Rajpert-De Meyts E.et al. Lack of p19 INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene. 19:2000;4146-4150.
35. Bartkova J., Thullberg M., Rajpert-De Meyts E.et al. Cell cycle regulators in testicular cancer. loss of p18 INK4C marks progression from carcinoma in situ to invasive germ cell tumours Int. J. Cancer. 85:2000;370-375.
36. Lundberg A.S., Weinberg R.A. Control of the cell cycle and apoptosis. Eur. J. Cancer. 35:1999;531-539.
37. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
38. Yan W., Kero J., Suminen J.et al. Differential expression and regulation of the retinoblastoma family of proteins during testicular development and spermatogenesis. roles in the control of germ cell proliferation, differentiation and apoptosis Oncogene. 20:2001;1343-1356.
39. Strohmeyer T., Reismann P., Cordon-Cardo C.et al. Correlation between retinoblastoma gene expression and differentiation in human testicular tumours. Proc. Natl. Acad. USA. 88:1991;6662-6666.
40. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
41. Loveland K.L., Sclatt S. Stem cell factor and c-kit in the mammalian testis. lessons originating from mother natures gene knockouts J. Endcrinol. 153:1997;337-344.
42. Tian Q., Frierson H., Krystal G.et al. Activating c-kit gene mutations in human germ cell tumours. Am. J. Pathol. 154:1999;1643-1647.
43. Alizadeh A.A., Eisen M.B., Davis R.E.et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.). 403:2000;503-511.
44. Skotheim R.I., Monni O., Mousses S.et al. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res. 62:2002;2359-2364.
45. Lutzker S.G., Barnard N.J. Testicular germ cell tumours. molecular understanding and clinical implications Mol. Med. Today. Sept:1998;404-411.